Article
Effect of terbinafine on the pharmacokinetics and pharmacodynamics of desipramine in healthy volunteers identified as cytochrome P450 2D6 (CYP2D6) extensive metabolizers.
Journal of clinical pharmacology - 1 Nov 2002
Madani Soraya, Barilla Denise, Cramer Jeffrey, Wang Yibin, Paul Carle
Abstract excerpt
Terbinafine-CYP2D6 inhibition was evaluated by assessing 48-hour concentration-time profiles of the tricyclic antidepressant desipramine in 12 healthy volunteers identified as extensive cytochrome P450 2D6 (CYP2D6) metabolizers by genotyping and phenotyping. Pharmacokinetics was evaluated at base...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
